Aquamantys Device
DeviceThe Aquamantys is used for hemostasis in patients randomized to receive total knee arthroplasty with the device.
NCT Number: NCT01003080
The use of Aquamantys during total knee arthroplasty will reduce drain output and the necessity for blood transfusions.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Jack D. Weiler Hospital-Division of Montefiore Medical Center, The Bronx, New York, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Aquamantys is used for hemostasis in patients randomized to receive total knee arthroplasty with the device.
The active comparator arm will receive the "standard-of-care" for hemostasis during total knee arthroplasty. This is achieved with a unipolar Bovie electrocauterization device.
Time frame: First 24 hours following surgery.
This is a measure of the average drain output collected in the first 24 hours following surgery.
Montefiore Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04482400
Knee Arthroplasty
Columbia, South Carolina, United States
View Trial DetailsNCT06096727
Behavior, Knee Arthroplasty
Columbia, South Carolina, United States
View Trial DetailsNCT07059429
Agnosia, Analgesia
Moscow, Russia
View Trial DetailsNCT05999864
Knee Arthroplasty
Muğla, Turkey (Türkiye)
View Trial Details